By Richard Ware
I have always been healthy and active, so I was stunned earlier this year when I was diagnosed with myelodysplastic syndrome, a form of leukemia I was referred to a cancer treatment center in Utah where I felt rushed into a treatment that was presented as the only option. I contacted MD Anderson for a second opinion and higher level of competence and a new, cutting-edge treatment option for my condition.
They recommended that I try an experimental chemotherapy treatment regimen that had shown positive outcomes for otherwise healthy middle-aged people like me. I began chemotherapy in September and have already seen positive results. Dr. Courtney DiNardo is my primary physician.
Dr. DiNardo asked if I would be willing to participate in MD Anderson’s collaboration with IBM to use Watson. As a scientist developing new supplements for cattle health, I’m excited to be a part of this powerful combination of cutting-edge research and next-generation computing. I hope that by contributing my data to this effort, I can help not just myself but other patients—and help in the eradication of cancer.
I have come to realize the importance of seeking out excellence in any field that impacts your life. For me, MD Anderson set the standard for excellence in medical care for leukemia. There is no doubt that through this new collaborative effort, they will continue to make meaningful breakthroughs in the pursuit to treat and eliminate cancer.